---
figid: PMC8826051__tbac001f1
figtitle: Novel development strategies and challenges for anti-Her2 antibody-drug
  conjugates
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8826051
filename: tbac001f1.jpg
figlink: /pmc/articles/PMC8826051/figure/f1/
number: F1
caption: Schematic representation of Her2 signaling pathway.
papertitle: Novel development strategies and challenges for anti-Her2 antibody-drug
  conjugates.
reftext: Xinling Zhang, et al. Antib Ther. 2022 Jan;5(1):18-29.
year: '2022'
doi: 10.1093/abt/tbac001
journal_title: Antibody Therapeutics
journal_nlm_ta: Antib Ther
publisher_name: Oxford University Press
keywords: antibody-drug conjugate | human epidermal growth factor 2 | linker payload
  | cytotoxic drug | breast cancer
automl_pathway: 0.9509471
figid_alias: PMC8826051__F1
figtype: Figure
redirect_from: /figures/PMC8826051__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8826051__tbac001f1.html
  '@type': Dataset
  description: Schematic representation of Her2 signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ecd
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Mtor
  - Tor
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - ECD
  - SEM1
  - ERBB2
  - EGFR
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ERBB3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - ERBB4
---
